Akarsu Saadet, Kilic Mehmet, Yilmaz Erdal, Aydin Mustafa, Taskin Erdal, Aygun A Denizmen
Department of Pediatrics, Medical Faculty of Firat University, Elazig, Turkey.
Acta Haematol. 2006;116(1):46-50. doi: 10.1159/000092347.
The prevalence rates of hypoferritinemia (IDec/one abnormal indicator), iron deficiency (IDef/two abnormal indicators) and iron deficiency anemia (IDA) in children who were referred to the outpatient clinics of the Department of Pediatrics for the first time within 1 month were investigated. Exclusion criteria were iron therapy before and during the study period and a history of chronic illness. Acute-phase reactants, such as erythrocyte sedimentation rate and C-reactive protein levels, were measured in all cases indicative of infectious diseases. Blood samples were obtained from each study patient admitted to the outpatient clinics during the study period. The hospital charts were later further evaluated, and samples of patients with any current illness known to interact with the iron status of the patient were discarded, and patients were contacted to supply new samples about 1 month after treatment of the infection. Thus, in patients with indications of an infection, samples obtained 1 month after treatment were assessed. The children (n = 557) were divided into four age groups: those aged 4 months to 2 years (group I), 2-6 years (group II), 7-12 years (group III) and 12-18 years (group IV). Children with a decrease in serum ferritin levels without anemia (IDec), and those with lower ferritin, transferrin saturation (TS) and serum iron (SI) concentration (IDef) were evaluated. IDA was diagnosed if hemoglobin (Hb) concentrations were lower than those adjusted for age, ferritin <12 ng/ml and TS <or=16% and if SI was decreased. IDec, IDef and IDA were detected in 26, 11.1 and 12.7% of the patients, respectively. Only 50.1% of the patients visiting the outpatient clinics were found to be normal. The rates of IDec (28.9%), IDef (21.9%) and IDA (26.2%) were highest in group I. IDec had the highest percentages in all groups. In group I, the rates of IDec, IDef, and IDA were 37.2, 66.1 and 69%, respectively. SI concentration was abnormal in 77.1% of the cases in group I (4 months to 2 years of age). Half of the patients referred to the outpatient clinics were suffering from abnormalities related to lower SI concentrations. Close monitoring and treatment of iron deficiency is advised especially in early childhood.
对在1个月内首次到儿科门诊就诊的儿童低铁蛋白血症(IDec/一项异常指标)、缺铁(IDef/两项异常指标)和缺铁性贫血(IDA)的患病率进行了调查。排除标准为研究期间之前和期间的铁剂治疗以及慢性病病史。对所有提示传染病的病例测量急性期反应物,如红细胞沉降率和C反应蛋白水平。在研究期间从门诊收治的每位研究患者采集血样。随后进一步评估医院病历,丢弃已知与患者铁状态相互作用的任何当前疾病患者的样本,并在感染治疗后约1个月联系患者提供新样本。因此,对于有感染迹象的患者,评估治疗1个月后采集的样本。将儿童(n = 557)分为四个年龄组:4个月至2岁(I组)、2 - 6岁(II组)、7 - 12岁(III组)和12 - 18岁(IV组)。对血清铁蛋白水平降低但无贫血的儿童(IDec)以及铁蛋白、转铁蛋白饱和度(TS)和血清铁(SI)浓度较低的儿童(IDef)进行评估。如果血红蛋白(Hb)浓度低于年龄校正值、铁蛋白<12 ng/ml、TS<或 = 16%且SI降低,则诊断为IDA。IDec、IDef和IDA在患者中的检出率分别为26%、11.1%和12.7%。仅发现50.1%到门诊就诊的患者正常。I组中IDec(28.9%)、IDef(21.9%)和IDA(26.2%)的患病率最高。IDec在所有组中的百分比最高。在I组中,IDec、IDef和IDA的患病率分别为37.2%、66.1%和69%。I组(4个月至2岁)中77.1%的病例SI浓度异常。到门诊就诊的患者中有一半患有与较低SI浓度相关的异常。建议尤其在幼儿期密切监测和治疗缺铁情况。